Scientists have developed an anti-cancer agent that, in lower doses, can kill cancer cells and spare healthy ones — presenting a favourable therapeutic scenario in which relapse is unlikely.

Cancer immunotherapy has proven efficacy in ... to be present in tumors—approximately 0.1%—to achieve effective anticancer immunity. Direct cell reprogramming induces functional cDC1-like ...

Evidence has since emerged suggesting that anti-inflammatory drugs might benefit some patients with colon cancer, but not others. One possibility for this is that patients who have a blood test ...